Drug details

Ixifi (infliximab-qbtx for injection, for intravenous use)

type of DMARDs, TNF Inhibitors, Monoclonal Antibodies

Ixifi (infliximab-qbtx) for Injection is a tumor necrosis factor (TNF) blocker indicated for reducing signs and symptoms of Crohn's disease, pediatric Crohn's disease, ulcerative colitis (UC), rheumatoid arthritis (RA), ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.

The drug is often used to treat Ankylosing spondylitis , Psoriatic arthritis , Ulcerative colitis .

This drug may have the following side effects:

• diarrhea,
• nausea,
• headache,
• infusion-related reactions,
• fatigue,
• abdominal pain,
• indigestion,
• rash,
• itching,
• fever,
• yeast infection,
• joint pain,
• and high blood pressure (hypertension).

The following drugs are related to Ixifi, either as a replacement or used together:

• Lotronex (alosetron hydrochloride)
• Anusol Rectal (hydrocortisone acetate rectal suppositories)
• OsmoPrep (sodium phosphate monobasic monohydrate and sodium phosphate dibasic anhydrous)